Related references
Note: Only part of the references are listed.Suppression of hepatic stellate cell activation by microRNA-29b
Yumiko Sekiya et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation
Chao Chen et al.
EXPERIMENTAL CELL RESEARCH (2011)
Micro-RNA Profiling Reveals a Role for miR-29 in Human and Murine Liver Fibrosis
Christoph Roderburg et al.
HEPATOLOGY (2011)
Hepatitis C Virus Infection and Hepatic Stellate Cell Activation Downregulate miR-29: miR-29 Overexpression Reduces Hepatitis C Viral Abundance in Culture
Sarmistha Bandyopadhyay et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C
Kazutoyo Morita et al.
LIVER INTERNATIONAL (2011)
miRBase: integrating microRNA annotation and deep-sequencing data
Ana Kozomara et al.
NUCLEIC ACIDS RESEARCH (2011)
Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction
Monika Kwiecinski et al.
PLOS ONE (2011)
The Role of MicroRNAs in Human Liver Cancers
Chiara Braconi et al.
SEMINARS IN ONCOLOGY (2011)
microRNAs: Fad or future of liver disease
Ashley M. Lakner et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation
Senthil K. Venugopal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
MicroRNA-29, a Key Regulator of Collagen Expression in Systemic Sclerosis
Britta Maurer et al.
ARTHRITIS AND RHEUMATISM (2010)
Suppression of type I collagen production by microRNA-29b in cultured human stellate cells
Tomohiro Ogawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Hepatic Stellate Cell-Specific Gene Silencing Induced by an Artificial MicroRNA for Antifibrosis In Vitro
Ying Chang et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
MeCP2 Controls an Epigenetic Pathway That Promotes Myofibroblast Transdifferentiation and Fibrosis
Jelena Mann et al.
GASTROENTEROLOGY (2010)
Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells
Can-Jie Guo et al.
APOPTOSIS (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease
X. Jin et al.
DIGESTIVE AND LIVER DISEASE (2009)
Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways
Can-Jie Guo et al.
FEBS JOURNAL (2009)
Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation
Juling Ji et al.
FEBS LETTERS (2009)
Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR
U. Siebolts et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
miR-29 miRNAs activate p53 by targeting p85a and CDC42
Seong-Yeon Park et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
NF-κB-YY1-miR-29 Regulatory Circuitry in Skeletal Myogenesis and Rhabdomyosarcoma
Huating Wang et al.
CANCER CELL (2008)
Mechanisms of hepatic fibrogenesis
Scott L. Friedman
GASTROENTEROLOGY (2008)
Nonalcoholic Steatohepatitis Is Associated with Altered Hepatic MicroRNA Expression
Onpan Cheung et al.
HEPATOLOGY (2008)
MicroRNA involvement in hepatocellular carcinoma
Laura Gramantieri et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
Eva van Rooij et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions
Chad J. Creighton et al.
RNA (2008)
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B
Muller Fabbri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
mir-29 regulates Mcl-1 protein expression and apoptosis
J. L. Mott et al.
ONCOGENE (2007)
Expression of angiotensin II receptor type 1 is reduced in advanced rat liver fibrosis
Ulrich Toex et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis
Tatiana Kisseleva et al.
JOURNAL OF HEPATOLOGY (2006)
Crosstalk between PDGF and IGF-I receptors in rat liver myofibroblasts: implication for liver fibrogenesis
Ruslan Novosyadlyy et al.
LABORATORY INVESTIGATION (2006)
Coordinate activation of intracellular signaling pathways by insulin-like growth factor-1 and platelet-derived growth factor in rat hepatic stellate cells
Kim R. Bridle et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2006)
Systematic identification of microRNA functions by combining target prediction and expression profiling
XW Wang et al.
NUCLEIC ACIDS RESEARCH (2006)
Expression patterns of PDGF-A, -B, -C and -D and the PDGF-receptors α and β in activated rat hepatic stellate cells (HSC)
K Breitkopf et al.
CYTOKINE (2005)
Combinatorial microRNA target predictions
A Krek et al.
NATURE GENETICS (2005)
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma
JS Campbell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
LP Lim et al.
NATURE (2005)
IGF-I induces DNA synthesis and apoptosis in rat liver hepatic stellate cells (HSC) but DNA synthesis and proliferation in rat liver myofibroblasts (rMF)
B Saile et al.
LABORATORY INVESTIGATION (2004)
Hepatitis C and liver fibrosis
D Schuppan et al.
CELL DEATH AND DIFFERENTIATION (2003)
Activation of hepatic stellate cells - A key issue in liver fibrosis
HL Reeves et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2002)
Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF α and β receptor
DG Gilbertson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The IGF axis and hepatocarcinogenesis
JG Scharf et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2001)
Share Paper
